Actively Recruiting

Phase 2
Age: 18Years - 99Years
All Genders
NCT07431177

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

Led by Novartis Pharmaceuticals · Updated on 2026-05-14

210

Participants Needed

22

Research Sites

205 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The main purpose of this multicenter, randomized, double-blind, placebo-controlled Phase 2b study is to investigate the safety and efficacy of GIA632 in participants with NSV and to identify the optimal dose to be promoted into the confirmatory Phase 3 program.

CONDITIONS

Official Title

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

Who Can Participate

Age: 18Years - 99Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed informed consent before participation
  • Male or female assigned at birth aged 18 years or older at screening
  • Diagnosed with non-segmental vitiligo confirmed by physical exam
  • Non-segmental vitiligo covering at least 0.5% of facial body surface area and F-VASI score of 0.5 or more
  • Non-segmental vitiligo covering 3% or more of non-facial body surface area (excluding hands and feet) with T-VASI score between 3 and 60
Not Eligible

You will not qualify if you...

  • Unable or unwilling to follow study procedures or complete questionnaires
  • Have segmental or mixed vitiligo or other skin conditions that interfere with assessments
  • Previous use of biologic drugs targeting IL-15 or IL-15 receptors
  • Prior attempt or completion of depigmentation therapy for non-segmental vitiligo
  • Use of prohibited medications or treatments as defined by the study protocol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 22 locations

1

Cahaba Derm and skin hlth ctr 27

Birmingham, Alabama, United States, 35244

Actively Recruiting

2

Clinical Trials Research Institute

Thousand Oaks, California, United States, 91320

Actively Recruiting

3

Miami Derm and Laser Institute

Miami, Florida, United States, 33173

Actively Recruiting

4

Global Clinical Professionals

St. Petersburg, Florida, United States, 33714

Actively Recruiting

5

Dawes Fretzin Clinical Rea Group

Indianapolis, Indiana, United States, 46256

Actively Recruiting

6

Hamzavi Dermatology

Fort Gratiot, Michigan, United States, 48059

Actively Recruiting

7

Revival Research Institute

Troy, Michigan, United States, 48084

Actively Recruiting

8

Skin Specialists PC

Omaha, Nebraska, United States, 68144

Actively Recruiting

9

Las Vegas Dermatology

Las Vegas, Nevada, United States, 89144

Actively Recruiting

10

Equity Medical

The Bronx, New York, United States, 10455

Actively Recruiting

11

International Clinical Research Tennessee LCC

Murfreesboro, Tennessee, United States, 37130

Actively Recruiting

12

Center for Clinical Studies

Houston, Texas, United States, 77030

Actively Recruiting

13

Austin Inst for Clinical Research

Pflugerville, Texas, United States, 78660

Actively Recruiting

14

Virginia Clinical Research

Norfolk, Virginia, United States, 23507

Actively Recruiting

15

Novartis Investigative Site

Sydney, New South Wales, Australia, 2010

Actively Recruiting

16

Novartis Investigative Site

Waitara, New South Wales, Australia, 2077

Actively Recruiting

17

Novartis Investigative Site

Melbourne, Victoria, Australia, 3000

Actively Recruiting

18

Novartis Investigative Site

Mississauga, Ontario, Canada, L4Y 4C5

Actively Recruiting

19

Novartis Investigative Site

Newmarket, Ontario, Canada, L3Y 5G8

Actively Recruiting

20

Novartis Investigative Site

Toronto, Ontario, Canada, M3H 5Y8

Actively Recruiting

21

Novartis Investigative Site

Québec, Quebec, Canada, G1V 4X7

Actively Recruiting

22

Novartis Investigative Site

Urayasu, Chiba, Japan, 279-0021

Actively Recruiting

Loading map...

Research Team

N

Novartis Pharmaceuticals

CONTACT

N

Novartis Pharmaceuticals

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

5

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo | DecenTrialz